• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

载脂蛋白 E 与载脂蛋白 C-III 的 VLDL 和 LDL 与较低的冠心病风险相关。

Apolipoprotein E in VLDL and LDL with apolipoprotein C-III is associated with a lower risk of coronary heart disease.

机构信息

Universidad de los Andes, School of Medicine, Bogotá, Colombia.

出版信息

J Am Heart Assoc. 2013 May 14;2(3):e000130. doi: 10.1161/JAHA.113.000130.

DOI:10.1161/JAHA.113.000130
PMID:23672999
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC3698772/
Abstract

BACKGROUND

Low-density lipoprotein (LDL) with apolipoprotein C-III (apoC-III) is the lipoprotein species that most strongly predicts initial and recurring coronary heart disease (CHD) events in several cohorts. Thus, a large portion of the CHD risk conferred by LDL may be attributable to LDL that contains apoC-III. Very-low-density lipoprotein (VLDL) and LDL with apoC-III have varying amounts of apoE. We hypothesized that a high content of apoE lessens the adverse influence of apoC-III on the risk of CHD because it promotes the clearance of VLDL and LDL from plasma.

METHODS AND RESULTS

We studied 2 independent cohorts, the Nurses' Health Study, composed of women, and the Health Professionals Follow-up Study, composed of men. These cohorts contributed to this study 322 women and 418 men initially free of CVD who developed a fatal or nonfatal myocardial infarction during 10 to 14 years of follow-up and matched controls who remained free of CHD. The apoE content of LDL with apoC-III was inversely associated with CHD after multivariable adjustment (relative risk for top versus bottom quintile 0.53, 95% CI 0.35 to 0.80). The apoE content of VLDL with apoC-III had a similar inverse association with CHD. The highest risks were associated with a high apoB concentration and a low apoE content of LDL with apoC-III or of VLDL+LDL with apoC-III. The observed associations were in both male and female cohorts and independent of traditional CHD risk factors and of C-reactive protein.

CONCLUSIONS

An increased apoE content in VLDL and LDL with apoC-III was associated with a lower risk of CHD. Strategies to enrich VLDL and LDL in apoE are worth exploring for the prevention of CHD.

摘要

背景

载脂蛋白 C-III(apoC-III)的低密度脂蛋白(LDL)是在多个队列中预测首发和复发性冠心病(CHD)事件最强的脂蛋白种类。因此,LDL 所带来的 CHD 风险的很大一部分可能归因于含有 apoC-III 的 LDL。极低密度脂蛋白(VLDL)和载有 apoC-III 的 LDL 含有不同量的 apoE。我们假设 apoE 含量高会减轻 apoC-III 对 CHD 风险的不利影响,因为它可以促进 VLDL 和 LDL 从血浆中清除。

方法和结果

我们研究了两个独立的队列,女性的护士健康研究和男性的健康专业人员随访研究。这些队列为这项研究贡献了 322 名最初无 CVD 的女性和 418 名无 CHD 的男性对照者,他们在 10 至 14 年的随访期间发生了致命或非致命性心肌梗死。在多变量调整后,载有 apoC-III 的 LDL 的 apoE 含量与 CHD 呈负相关(最高五分位与最低五分位的相对风险为 0.53,95%CI 为 0.35 至 0.80)。载有 apoC-III 的 VLDL 的 apoE 含量与 CHD 也呈类似的负相关。与 LDL 载 apoC-III 或 VLDL+LDL 载 apoC-III 的 apoB 浓度高、apoE 含量低相关的风险最高。观察到的相关性在男性和女性队列中均存在,并且独立于传统的 CHD 危险因素和 C 反应蛋白。

结论

载有 apoC-III 的 VLDL 和 LDL 中 apoE 含量增加与 CHD 风险降低相关。富含 apoE 的 VLDL 和 LDL 的策略值得探索用于 CHD 的预防。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/2a02/3698772/22574f85d733/jah3-2-e000130-g3.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/2a02/3698772/346b0ebeaee8/jah3-2-e000130-g1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/2a02/3698772/d758e564c822/jah3-2-e000130-g2.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/2a02/3698772/22574f85d733/jah3-2-e000130-g3.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/2a02/3698772/346b0ebeaee8/jah3-2-e000130-g1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/2a02/3698772/d758e564c822/jah3-2-e000130-g2.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/2a02/3698772/22574f85d733/jah3-2-e000130-g3.jpg

相似文献

1
Apolipoprotein E in VLDL and LDL with apolipoprotein C-III is associated with a lower risk of coronary heart disease.载脂蛋白 E 与载脂蛋白 C-III 的 VLDL 和 LDL 与较低的冠心病风险相关。
J Am Heart Assoc. 2013 May 14;2(3):e000130. doi: 10.1161/JAHA.113.000130.
2
Low-density lipoproteins containing apolipoprotein C-III and the risk of coronary heart disease.载脂蛋白 C-III 的低密度脂蛋白与冠心病风险。
Circulation. 2011 Nov 8;124(19):2065-72. doi: 10.1161/CIRCULATIONAHA.111.056986. Epub 2011 Oct 10.
3
[THE LIPOLYSIS IN PHYLOGENETICALLY EARLY LIPOPROTEINS OF LOW DENSITY AND MORE LATER LIPOPROTEINS OF VERY LOW DENSITY: FUNCTION AND DIAGNOSTIC VALUE OF APOE AND APOC-III].[低密度脂蛋白在系统发育早期脂蛋白中的脂解作用以及极低密度脂蛋白在更晚期脂蛋白中的脂解作用:载脂蛋白E和载脂蛋白C-III的功能及诊断价值]
Klin Lab Diagn. 2015 Dec;60(12):4-14.
4
Distinct patterns of lipoproteins with apoB defined by presence of apoE or apoC-III in hypercholesterolemia and hypertriglyceridemia.高胆固醇血症和高甘油三酯血症中,由载脂蛋白E或载脂蛋白C-III的存在所定义的含载脂蛋白B的不同脂蛋白模式。
J Lipid Res. 2001 Aug;42(8):1239-49.
5
Apolipoprotein C-III and the metabolic basis for hypertriglyceridemia and the dense low-density lipoprotein phenotype.载脂蛋白 C-III 与高甘油三酯血症和密致低密脂蛋白表型的代谢基础。
Circulation. 2010 Apr 20;121(15):1722-34. doi: 10.1161/CIRCULATIONAHA.109.875807. Epub 2010 Apr 5.
6
Apolipoprotein C-III, a strong discriminant of coronary risk in men and a determinant of the metabolic syndrome in both genders.载脂蛋白C-III,男性冠心病风险的强判别指标,也是两性代谢综合征的决定因素。
Atherosclerosis. 2003 May;168(1):81-9. doi: 10.1016/s0021-9150(03)00025-x.
7
Antisense inhibition of apoB synthesis with mipomersen reduces plasma apoC-III and apoC-III-containing lipoproteins.米泊美生抑制载脂蛋白 B 合成可降低血浆载脂蛋白 C-III 和载脂蛋白 C-III 脂蛋白。
J Lipid Res. 2012 Apr;53(4):784-91. doi: 10.1194/jlr.P021717. Epub 2012 Feb 2.
8
Apolipoprotein C-III displacement of apolipoprotein E from VLDL: effect of particle size.载脂蛋白C-III从极低密度脂蛋白(VLDL)上置换载脂蛋白E:颗粒大小的影响。
J Lipid Res. 1999 Oct;40(10):1875-82.
9
In-vivo metabolism of VLDL-apolipoprotein-B, -CIII and -E in normolipidemic subjects.正常血脂受试者中极低密度脂蛋白载脂蛋白B、CIII和E的体内代谢
Nutr Metab Cardiovasc Dis. 2006 Apr;16(3):215-21. doi: 10.1016/j.numecd.2005.06.004. Epub 2005 Nov 2.
10
Lipoprotein distribution of apolipoprotein C-III and its relationship to the presence in plasma of triglyceride-rich remnant lipoproteins.载脂蛋白C-III的脂蛋白分布及其与富含甘油三酯的残余脂蛋白在血浆中存在的关系。
Metabolism. 2001 Jan;50(1):112-9. doi: 10.1053/meta.2001.19452.

引用本文的文献

1
Alterations in LDL and HDL after an ischemic stroke associated with carotid atherosclerosis are reversed after 1 year.与颈动脉粥样硬化相关的缺血性中风后,低密度脂蛋白和高密度脂蛋白的改变在1年后会逆转。
J Lipid Res. 2025 Feb;66(2):100739. doi: 10.1016/j.jlr.2024.100739. Epub 2024 Dec 31.
2
Isoform- and cell-state-specific APOE homeostasis and function.异构体和细胞状态特异性的载脂蛋白E稳态与功能。
Neural Regen Res. 2024 Nov 1;19(11):2456-2466. doi: 10.4103/NRR.NRR-D-23-01470. Epub 2024 Jan 31.
3
Spotlight on very-low-density lipoprotein as a driver of cardiometabolic disorders: Implications for disease progression and mechanistic insights.

本文引用的文献

1
Low-density lipoproteins containing apolipoprotein C-III and the risk of coronary heart disease.载脂蛋白 C-III 的低密度脂蛋白与冠心病风险。
Circulation. 2011 Nov 8;124(19):2065-72. doi: 10.1161/CIRCULATIONAHA.111.056986. Epub 2011 Oct 10.
2
Apolipoprotein C-III and the metabolic basis for hypertriglyceridemia and the dense low-density lipoprotein phenotype.载脂蛋白 C-III 与高甘油三酯血症和密致低密脂蛋白表型的代谢基础。
Circulation. 2010 Apr 20;121(15):1722-34. doi: 10.1161/CIRCULATIONAHA.109.875807. Epub 2010 Apr 5.
3
Metabolism of very-low-density lipoprotein and low-density lipoprotein containing apolipoprotein C-III and not other small apolipoproteins.
聚焦极低密度脂蛋白作为心血管代谢紊乱的驱动因素:对疾病进展的影响及机制洞察
Front Cardiovasc Med. 2022 Oct 4;9:993633. doi: 10.3389/fcvm.2022.993633. eCollection 2022.
4
Emerging Evidence of Pathological Roles of Very-Low-Density Lipoprotein (VLDL).越来越多的证据表明极低密度脂蛋白(VLDL)具有病理性作用。
Int J Mol Sci. 2022 Apr 13;23(8):4300. doi: 10.3390/ijms23084300.
5
Coronary Heart Disease in Type 2 Diabetes Mellitus: Genetic Factors and Their Mechanisms, Gene-Gene, and Gene-Environment Interactions in the Asian Populations.2 型糖尿病中的冠心病:亚洲人群中的遗传因素及其机制、基因-基因和基因-环境相互作用。
Int J Environ Res Public Health. 2022 Jan 6;19(2):647. doi: 10.3390/ijerph19020647.
6
TNFα-Induced LDL Cholesterol Accumulation Involve Elevated LDLR Cell Surface Levels and SR-B1 Downregulation in Human Arterial Endothelial Cells.TNFα 诱导的 LDL 胆固醇积累涉及人动脉内皮细胞中 LDLR 细胞表面水平的升高和 SR-B1 的下调。
Int J Mol Sci. 2021 Jun 9;22(12):6236. doi: 10.3390/ijms22126236.
7
Genetics of Triglyceride-Rich Lipoproteins Guide Identification of Pharmacotherapy for Cardiovascular Risk Reduction.富含甘油三酯的脂蛋白的遗传学指导心血管风险降低的药物治疗选择。
Cardiovasc Drugs Ther. 2021 Jun;35(3):677-690. doi: 10.1007/s10557-021-07168-0. Epub 2021 Mar 12.
8
CoQ Deficient Endothelial Cell Culture Model for the Investigation of CoQ Blood-Brain Barrier Transport.用于研究辅酶Q血脑屏障转运的辅酶Q缺乏内皮细胞培养模型
J Clin Med. 2020 Oct 10;9(10):3236. doi: 10.3390/jcm9103236.
9
Apolipoprotein E gene polymorphism and renal function are associated with apolipoprotein E concentration in patients with chronic kidney disease.载脂蛋白 E 基因多态性与肾功能与慢性肾脏病患者载脂蛋白 E 浓度相关。
Lipids Health Dis. 2019 Mar 9;18(1):60. doi: 10.1186/s12944-019-1003-x.
10
Hypertriglyceridemia and cardiovascular risk: a cautionary note about metabolic confounding.高甘油三酯血症与心血管风险:代谢因素混杂的警示。
J Lipid Res. 2018 Jul;59(7):1266-1275. doi: 10.1194/jlr.R082271. Epub 2018 May 16.
载脂蛋白 C-III 而非其他小载脂蛋白的极低密度脂蛋白和低密度脂蛋白的代谢。
Arterioscler Thromb Vasc Biol. 2010 Feb;30(2):239-45. doi: 10.1161/ATVBAHA.109.197830. Epub 2009 Nov 12.
4
Plasma levels of apolipoprotein E and risk of stroke in old age.老年人群中载脂蛋白E的血浆水平与中风风险
Ann N Y Acad Sci. 2007 Apr;1100:140-7. doi: 10.1196/annals.1395.012.
5
Rapid turnover of apolipoprotein C-III-containing triglyceride-rich lipoproteins contributing to the formation of LDL subfractions.富含载脂蛋白C-III的甘油三酯丰富脂蛋白的快速周转有助于低密度脂蛋白亚组分的形成。
J Lipid Res. 2007 May;48(5):1190-203. doi: 10.1194/jlr.P600011-JLR200. Epub 2007 Feb 21.
6
ApoE plasma levels and risk of cardiovascular mortality in old age.载脂蛋白E血浆水平与老年心血管疾病死亡率风险
PLoS Med. 2006 Jun;3(6):e176. doi: 10.1371/journal.pmed.0030176. Epub 2006 May 9.
7
Apolipoprotein CIII in apolipoprotein B lipoproteins enhances the adhesion of human monocytic cells to endothelial cells.载脂蛋白B脂蛋白中的载脂蛋白CIII增强人单核细胞与内皮细胞的黏附。
Circulation. 2006 Feb 7;113(5):691-700. doi: 10.1161/CIRCULATIONAHA.105.591743.
8
Indices related to apo CII and CIII serum concentrations and coronary heart disease: a case-control study.与载脂蛋白CII和CIII血清浓度及冠心病相关的指标:一项病例对照研究。
Prev Med. 2003 Jul;37(1):18-22. doi: 10.1016/s0091-7435(03)00051-3.
9
Apolipoprotein C-III, a strong discriminant of coronary risk in men and a determinant of the metabolic syndrome in both genders.载脂蛋白C-III,男性冠心病风险的强判别指标,也是两性代谢综合征的决定因素。
Atherosclerosis. 2003 May;168(1):81-9. doi: 10.1016/s0021-9150(03)00025-x.
10
LDL containing apolipoprotein CIII is an independent risk factor for coronary events in diabetic patients.含有载脂蛋白CIII的低密度脂蛋白是糖尿病患者发生冠状动脉事件的独立危险因素。
Arterioscler Thromb Vasc Biol. 2003 May 1;23(5):853-8. doi: 10.1161/01.ATV.0000066131.01313.EB. Epub 2003 Mar 13.